7th January 2023

mRNA cancer therapies planned for 2030

BioNTech has announced a strategic partnership with the UK government to provide up to 10,000 patients with personalised mRNA cancer immunotherapies by 2030.

Read more...

2nd December 2022

Shocking decline in human sperm counts

A new study finds that human sperm counts fell by 62% in the last 50 years – possibly due to poor diets, combined with a toxic soup of "forever chemicals" in our air and water.

Read more...

17th November 2022

Lab-grown meat approved by FDA for first time

After a rigorous evaluation, UPSIDE Foods has become the first company to gain regulatory approval from the U.S. Food and Drug Administration (FDA) for a cellular agriculture product grown from animal cells.

Read more...

11th November 2022

New antibiotic achieves success in clinical trial

QPX9003, a new antibiotic for Gram-negative bacteria, has achieved success in a Phase I clinical trial.

Read more...

8th November 2022

Lab-grown blood cells transfused into people

The world's first clinical trial of laboratory grown red blood cells transfused into humans has begun in the UK.

Read more...

29th October 2022

World's largest government grant for cellular agriculture

The Dutch government has confirmed that it will allocate €60 million to support an ecosystem around cellular agriculture.

Read more...

10th October 2022

Coffee drinking linked to longer lifespan

A new study finds that drinking two to three cups of ground, instant, or decaffeinated coffee each day is associated with a longer lifespan and lower risk of cardiovascular disease compared with avoiding coffee.

Read more...

1st October 2022

New drug slows progression of Alzheimer's

A breakthrough in treating Alzheimer's disease is reported by pharmaceutical companies Eisai and Biogen, using a new drug called lecanemab, which is designed to remove beta-amyloid proteins from the brain.

Read more...

23rd September 2022

Climate extremes, viruses, social unrest ... war? We desperately need a Plan B

A guest piece by Richard Fox.

Read more...

13th September 2022

Gene-edited tomato can fight cancer and heart disease

U.S. regulators have approved a new purple tomato, genetically engineered to be packed with antioxidants and anthocyanins. The fruit will go on sale in 2023.

Read more...

« Previous

Next »